title: Anticoagulation in Atrial Fibrillation.
abstract: Patients with atrial fibrillation (AF) are at increased thromboembolic risk, and they suffer more severe strokes with worse outcomes. Most thromboembolic complications of AF are eminently preventable with oral anticoagulation, and the increasing numbers of AF patients mean antithrombotic therapy is the most crucial management aspect of this common arrhythmia. Despite the proven efficacy of warfarin, a string of limitations have meant that it is underused by physicians and patients alike. This has prompted a search for new anticoagulants that could overcome many of the inconveniences of dose variability and anticoagulant monitoring associated with warfarin, but without sacrificing efficacy in thromboprophylaxis. The arrival of new oral anticoagulants has been complemented by improved risk stratification schemes, which permit clinicians to easily and reliably identify patients requiring anticoagulation and their bleeding risk. These advances in AF treatment will hopefully translate into improved outcomes for patients, especially as our experience with the new agents grows.
authors.affiliation: Honorary Research Fellow.
authors.forename: Yousif
authors.initials: Y
authors.lastname: Ahmad
authors.affiliation: Professor of Cardiovascular Medicine, University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK.
authors.forename: Gregory Yh
authors.initials: GY
authors.lastname: Lip
keywords: Atrial fibrillation; oral anticoagulation; stroke prevention
references.citation: Thromb Haemost. 2011 Oct;106(4):739-49
references.pmid: 21789337
references.citation: JAMA. 2002 Nov 20;288(19):2441-8
references.pmid: 12435257
references.citation: N Engl J Med. 2012 Jan 5;366(1):9-19
references.pmid: 22077192
references.citation: Thromb Haemost. 2010 Apr;103(4):833-40
references.pmid: 20135077
references.citation: Stroke. 2006 Aug;37(8):1969-74
references.pmid: 16809573
references.citation: Stroke. 2006 Apr;37(4):1075-80
references.pmid: 16527999
references.citation: Thromb Haemost. 2008 Feb;99(2):295-304
references.pmid: 18278178
references.citation: J Am Coll Cardiol. 2011 Jan 11;57(2):173-80
references.pmid: 21111555
references.citation: Circulation. 2006 Jul 11;114(2):119-25
references.pmid: 16818816
references.citation: Stroke. 2006 Feb;37(2):447-51
references.pmid: 16385088
references.citation: Thromb Haemost. 2011 Dec;106(6):997-1011
references.pmid: 22048796
references.citation: N Engl J Med. 2010 Nov 4;363(19):1875-6
references.pmid: 21047252
references.citation: Cochrane Database Syst Rev. 2010 Apr 14;(4):CD003839
references.pmid: 20393937
references.citation: Heart. 2004 Mar;90(3):286-92
references.pmid: 14966048
references.citation: JAMA. 2001 Jun 13;285(22):2864-70
references.pmid: 11401607
references.citation: Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):84-91
references.pmid: 20031794
references.citation: J Thromb Thrombolysis. 2010 Jan;29(1):141-6
references.pmid: 19921101
references.citation: Thromb Haemost. 2010 Jun;103(6):1116-27
references.pmid: 20352166
references.citation: J Thromb Haemost. 2011 Jan;9(1):39-48
references.pmid: 21029359
references.citation: Thromb Haemost. 2010 Jan;103(1):34-9
references.pmid: 20062925
references.citation: Am J Med. 2002 Oct 1;113(5):432-5
references.pmid: 12401540
references.citation: Thromb Haemost. 2011 Nov;106(5):868-76
references.pmid: 21946939
references.citation: Thromb Haemost. 2010 Jul;104(1):49-60
references.pmid: 20539909
references.citation: Nat Rev Cardiol. 2011 Jul 26;8(10):602-6
references.pmid: 21788962
references.citation: N Engl J Med. 2009 Sep 17;361(12):1139-51
references.pmid: 19717844
references.citation: Chest. 2006 May;129(5):1155-66
references.pmid: 16685005
references.citation: J Thromb Haemost. 2005 Mar;3(3):514-21
references.pmid: 15748242
references.citation: Lancet. 2007 Aug 11;370(9586):493-503
references.pmid: 17693178
references.citation: Chest. 2010 Feb;137(2):263-72
references.pmid: 19762550
references.citation: N Engl J Med. 2011 May 12;364(19):1788-90
references.pmid: 21488759
references.citation: Am J Med. 2010 Jul;123(7):638-645.e4
references.pmid: 20609686
references.citation: Stroke. 1991 Aug;22(8):983-8
references.pmid: 1866765
references.citation: J Thromb Haemost. 2011 Aug;9(8):1460-7
references.pmid: 21624047
references.citation: Circulation. 2012 Feb 7;125(5):669-76
references.pmid: 22215856
references.citation: Am J Med. 1999 Feb;106(2):165-71
references.pmid: 10230745
references.citation: Europace. 2010 Oct;12(10):1360-420
references.pmid: 20876603
references.citation: N Engl J Med. 2011 Sep 15;365(11):981-92
references.pmid: 21870978
references.citation: Thromb Haemost. 2011 Nov;106(5):968-77
references.pmid: 21901239
references.citation: Am J Med. 2010 Sep;123(9):785-9
references.pmid: 20655037
references.citation: Lancet. 2009 Jan 10;373(9658):155-66
references.pmid: 19135613
references.citation: Thromb Haemost. 2012 May;107(5):838-47
references.pmid: 22318514
references.citation: Lancet. 2006 Jun 10;367 (9526):1903-12
references.pmid: 16765759
references.citation: N Engl J Med. 2011 Sep 8;365(10):883-91
references.pmid: 21830957
references.citation: Ann Intern Med. 1999 Oct 5;131(7):492-501
references.pmid: 10507957
references.citation: Thromb Res. 2006;118(3):321-33
references.pmid: 16198396
references.citation: Eur Heart J. 2004 Oct;25(19):1734-40
references.pmid: 15451152
references.citation: J Thromb Thrombolysis. 2000 Apr;9(3):283-92
references.pmid: 10728029
references.citation: Arch Intern Med. 2007 Feb 12;167(3):239-45
references.pmid: 17296878
references.citation: JAMA. 2001 May 9;285(18):2370-5
references.pmid: 11343485